2949-9283

hLife

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 205 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact205 DOIs
2

Attach ORCID iDs across 47 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact47 DOIs
3

Deposit reference lists for 14 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact14 DOIs

DOIs for this ISSN

Showing the top 5 of 205 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Status and challenges of global antimicrobial resistance con… (10.1016/j.hlife.2023.11.004)
Abstract References ORCID
95.91 18
2 Global public health crisis response: A roundtable discussio… (10.1016/j.hlife.2023.10.001)
Abstract References ORCID
90.31 15
3 Emergence of hypervirulent Pseudomonas aeruginosa pathotypic… (10.1016/j.hlife.2023.02.001)
Abstract ORCID
78.99 37
4 Mucosal vaccine development for respiratory viral infections (10.1016/j.hlife.2023.12.005)
Abstract ORCID
74.57 30
5 hLife: Linking basic research and clinical applications (10.1016/j.hlife.2023.10.005)
Abstract References ORCID
71.57 8
6 BCMA-CD19 bispecific CAR-T therapy in refractory chronic inf… (10.1016/j.hlife.2024.05.005)
Abstract ORCID
62.76 17
7 Neutrophils: Key players in the metabolic syndrome puzzle (10.1016/j.hlife.2025.01.003)
Abstract ORCID
61.52 16
8 Single-cell omics in tracing cellular heterogeneity of drug-… (10.1016/j.hlife.2024.01.004)
Abstract ORCID
58.80 14
9 Efficient inhibition of SARS-CoV-2 emerging EG.5, EG.5.1 and… (10.1016/j.hlife.2023.10.002)
Abstract ORCID
53.96 11
10 Time is now: Preparing for the next pandemic (10.1016/j.hlife.2024.12.008)
Abstract References
47.71 8
11 The discovery of T–B cell lineages: An interview with Profes… (10.1016/j.hlife.2023.03.001)
Abstract References ORCID
45.15 3
12 Medical journals: The past, present, and future (10.1016/j.hlife.2024.02.002)
Abstract References ORCID
45.15 3
13 Fecal microbiota transplantation in clinical practice: Prese… (10.1016/j.hlife.2024.01.006)
Abstract
43.51 54
14 A roadmap for exploring the untouched protein space for biol… (10.1016/j.hlife.2023.06.001)
Abstract ORCID
42.25 6
15 T cell cross-reactivity in autoimmune-like hepatitis trigger… (10.1016/j.hlife.2023.09.002)
Abstract ORCID
42.25 6
16 Lrrk2 promotes M1 macrophage polarization via regulating cyt… (10.1016/j.hlife.2024.12.003)
Abstract ORCID
42.25 6
17 Distinctive serotypes of SARS-related coronaviruses defined… (10.1016/j.hlife.2023.07.002)
Abstract
39.78 38
18 Understanding carbapenem-resistant hypervirulent Klebsiella… (10.1016/j.hlife.2024.06.005)
Abstract
39.78 38
19 International cooperation in science, technology, and health… (10.1016/j.hlife.2023.12.003)
Abstract References
38.91 5
20 Recent advances in surgical management strategies for hepato… (10.1016/j.hlife.2024.06.007)
Abstract ORCID
38.91 5
21 Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasa… (10.1016/j.hlife.2025.05.001)
Abstract ORCID
38.91 5
22 De novo design of covalent bonding peptides for target prote… (10.1016/j.hlife.2024.07.007)
Abstract
38.60 34
23 Evolutionary history and biological adaptation of Han Chines… (10.1016/j.hlife.2024.04.005)
Abstract
37.96 32
24 Population genomics of Central Asian peoples unveil ancient… (10.1016/j.hlife.2024.06.006)
Abstract
37.28 30
25 WHO revised bacterial priority pathogens list to encourage g… (10.1016/j.hlife.2024.10.003)
Abstract
37.28 30
26 Crucial functions of gut microbiota on gut–liver repair (10.1016/j.hlife.2025.01.001)
Abstract
37.28 30
27 Impact of COVID-19-related nonpharmaceutical interventions o… (10.1016/j.hlife.2024.03.005)
Abstract
35.78 26
28 The climate-health crisis: Innovation for adaptation (10.1016/j.hlife.2024.04.003)
Abstract References ORCID
35.78 2
29 Phenazines: Natural products for microbial growth control (10.1016/j.hlife.2023.11.005)
Abstract
35.37 25
30 Medical Journals in China: From Wuyi Huijiang to Chinese Med… (10.1016/j.hlife.2023.08.001)
Abstract ORCID
34.95 4
31 Mechanism of microglia-mediated neuroinflammation, associate… (10.1016/j.hlife.2024.11.006)
Abstract
34.51 23
32 Fecal microbiota transplantation: A new strategy to delay ag… (10.1016/j.hlife.2023.06.002)
Abstract
34.04 22
33 Regulatory functions and mechanisms of human microbiota in i… (10.1016/j.hlife.2024.03.004)
Abstract
31.97 18
34 Boosting CAR-T cell therapy with CRISPR technology (10.1016/j.hlife.2024.06.002)
Abstract
31.97 18
35 Personalized bacteriophage therapy for chronic biliary tract… (10.1016/j.hlife.2025.03.004)
Abstract
31.97 18
36 Mucosal immune responses in the lung during respiratory infe… (10.1016/j.hlife.2023.09.001)
Abstract
31.38 17
37 The structure of HSV-1 gB bound to a potent neutralizing ant… (10.1016/j.hlife.2023.12.004)
Abstract
31.38 17
38 A protective human antibody against respiratory syncytial vi… (10.1016/j.hlife.2023.09.003)
Abstract
30.76 16
39 Altitude adaptation: The unseen work of gut microbiota (10.1016/j.hlife.2024.11.004)
Abstract
30.76 16
40 Medicine has no borders, health unites us all: Henry Norman… (10.1016/j.hlife.2023.11.002)
Abstract ORCID
30.10 3
41 Aldo-keto reductase 1B: Much learned, much more to do (10.1016/j.hlife.2023.12.002)
Abstract
30.10 15
42 Is the time right for systematically serotyping SARS-related… (10.1016/j.hlife.2023.12.007)
Abstract
30.10 15
43 Candida albicans overgrowth impairs anti-PD-1 immunotherapy… (10.1016/j.hlife.2024.12.004)
Abstract ORCID
30.10 3
44 778th Xiangshan Science Conference convenes experts to explo… (10.1016/j.hlife.2025.04.006)
Abstract References
30.10 3
45 Carbapenem-resistant Klebsiella pneumoniae ST11 index from a… (10.1016/j.hlife.2025.04.007)
Abstract ORCID
30.10 3
46 Increasing priority for antifungal resistance research—Are w… (10.1016/j.hlife.2025.09.004)
Abstract ORCID
30.10 3
47 A human monoclonal antibody neutralizes SARS-CoV-2 Omicron v… (10.1016/j.hlife.2024.02.001)
Abstract
29.40 14
48 Heterogeneity and clinical genomics of blaKPC-2-producing, c… (10.1016/j.hlife.2024.04.001)
Abstract
29.40 14
49 Dissection of intratumor microbiome–host interactions at the… (10.1016/j.hlife.2024.09.001)
Abstract
29.40 14
50 Comparison of antigen-specific B cell responses reveals disp… (10.1016/j.hlife.2024.09.002)
Abstract
29.40 14